Combivent (Ipratropium Bromide / Albuterol Sulfate) - Current Clinical Trials

Combivent Related Clinical Trials

Respimat Combivent Trial in COPD [Completed]

4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma [Recruiting]

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [Completed]

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients. [Completed]

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients. [Completed]

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) [Completed]

Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients [Recruiting]

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]

Pathophysiological Mechanisms of Dyspnea and Activity-limitation in Mild Chronic Obstructive Pulmonary Disease (COPD) [Not yet recruiting]

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease [Not yet recruiting]

A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Recruiting]

Assessment of Ventilation-Perfusion Abnormalities in Patients With Stable Smoking-Related Airways Disease [Recruiting]

A Crossover Study in the Treatment of Patients With COPD [Completed]